ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pirfenidone Drugs Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-27Z17766
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pirfenidone Drugs Market Research Report 2024
BUY CHAPTERS

Global Pirfenidone Drugs Market Research Report 2024

Code: QYRE-Auto-27Z17766
Report
August 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Accord Healthcare
Amneal Pharmaceuticals
Sandoz Inc
ScieGen Pharmaceuticals
Gyre Pharmaceuticals
Apotex
TEVA
Kawin

Pirfenidone Drugs Market

Pirfenidone is an antifibrotic drug used primarily in the treatment of idiopathic pulmonary fibrosis(IPF),a progressive and debilitating lung disease characterized by scarring of lung tissue.It works by inhibiting the synthesis of transforming growth factor-beta(TGF-β),andpirfenidone exerts anti-inflammatory effects by suppressing the release of pro-inflammatory mediators and inhibiting the expression of genes associated with inflammation.
The global Pirfenidone Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pirfenidone Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pirfenidone Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pirfenidone Drugs include Roche, Accord Healthcare, Amneal Pharmaceuticals, Sandoz, ScieGen Pharmaceuticals, Gyre Pharmaceuticals, Apotex, Teva, Kawin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pirfenidone Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pirfenidone Drugs.
The Pirfenidone Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pirfenidone Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pirfenidone Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pirfenidone Drugs Market Report

Report Metric Details
Report Name Pirfenidone Drugs Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Accord Healthcare, Amneal Pharmaceuticals, Sandoz, ScieGen Pharmaceuticals, Gyre Pharmaceuticals, Apotex, Teva, Kawin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pirfenidone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pirfenidone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pirfenidone Drugs Market report?

Ans: The main players in the Pirfenidone Drugs Market are Roche, Accord Healthcare, Amneal Pharmaceuticals, Sandoz, ScieGen Pharmaceuticals, Gyre Pharmaceuticals, Apotex, Teva, Kawin

What are the Application segmentation covered in the Pirfenidone Drugs Market report?

Ans: The Applications covered in the Pirfenidone Drugs Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Pirfenidone Drugs Market report?

Ans: The Types covered in the Pirfenidone Drugs Market report are Capsules, Tablets

Recommended Reports

Respiratory Drug Markets

Fibrosis & Inflammatory

API & Formulation

1 Pirfenidone Drugs Market Overview
1.1 Product Definition
1.2 Pirfenidone Drugs by Type
1.2.1 Global Pirfenidone Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Capsules
1.2.3 Tablets
1.3 Pirfenidone Drugs by Application
1.3.1 Global Pirfenidone Drugs Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Pirfenidone Drugs Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Drugs Revenue 2019-2030
1.4.2 Global Pirfenidone Drugs Sales 2019-2030
1.4.3 Global Pirfenidone Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pirfenidone Drugs Market Competition by Manufacturers
2.1 Global Pirfenidone Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pirfenidone Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pirfenidone Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Pirfenidone Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pirfenidone Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pirfenidone Drugs, Product Type & Application
2.7 Global Key Manufacturers of Pirfenidone Drugs, Date of Enter into This Industry
2.8 Global Pirfenidone Drugs Market Competitive Situation and Trends
2.8.1 Global Pirfenidone Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pirfenidone Drugs Players Market Share by Revenue
2.8.3 Global Pirfenidone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pirfenidone Drugs Market Scenario by Region
3.1 Global Pirfenidone Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pirfenidone Drugs Sales by Region: 2019-2030
3.2.1 Global Pirfenidone Drugs Sales by Region: 2019-2024
3.2.2 Global Pirfenidone Drugs Sales by Region: 2025-2030
3.3 Global Pirfenidone Drugs Revenue by Region: 2019-2030
3.3.1 Global Pirfenidone Drugs Revenue by Region: 2019-2024
3.3.2 Global Pirfenidone Drugs Revenue by Region: 2025-2030
3.4 North America Pirfenidone Drugs Market Facts & Figures by Country
3.4.1 North America Pirfenidone Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pirfenidone Drugs Sales by Country (2019-2030)
3.4.3 North America Pirfenidone Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pirfenidone Drugs Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pirfenidone Drugs Sales by Country (2019-2030)
3.5.3 Europe Pirfenidone Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Pirfenidone Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pirfenidone Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Pirfenidone Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pirfenidone Drugs Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pirfenidone Drugs Sales by Country (2019-2030)
3.7.3 Latin America Pirfenidone Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pirfenidone Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pirfenidone Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pirfenidone Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pirfenidone Drugs Sales by Type (2019-2030)
4.1.1 Global Pirfenidone Drugs Sales by Type (2019-2024)
4.1.2 Global Pirfenidone Drugs Sales by Type (2025-2030)
4.1.3 Global Pirfenidone Drugs Sales Market Share by Type (2019-2030)
4.2 Global Pirfenidone Drugs Revenue by Type (2019-2030)
4.2.1 Global Pirfenidone Drugs Revenue by Type (2019-2024)
4.2.2 Global Pirfenidone Drugs Revenue by Type (2025-2030)
4.2.3 Global Pirfenidone Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Pirfenidone Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pirfenidone Drugs Sales by Application (2019-2030)
5.1.1 Global Pirfenidone Drugs Sales by Application (2019-2024)
5.1.2 Global Pirfenidone Drugs Sales by Application (2025-2030)
5.1.3 Global Pirfenidone Drugs Sales Market Share by Application (2019-2030)
5.2 Global Pirfenidone Drugs Revenue by Application (2019-2030)
5.2.1 Global Pirfenidone Drugs Revenue by Application (2019-2024)
5.2.2 Global Pirfenidone Drugs Revenue by Application (2025-2030)
5.2.3 Global Pirfenidone Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Pirfenidone Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Pirfenidone Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Company Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Accord Healthcare Pirfenidone Drugs Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Amneal Pharmaceuticals
6.3.1 Amneal Pharmaceuticals Company Information
6.3.2 Amneal Pharmaceuticals Description and Business Overview
6.3.3 Amneal Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amneal Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.3.5 Amneal Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Pirfenidone Drugs Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 ScieGen Pharmaceuticals
6.5.1 ScieGen Pharmaceuticals Company Information
6.5.2 ScieGen Pharmaceuticals Description and Business Overview
6.5.3 ScieGen Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ScieGen Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.5.5 ScieGen Pharmaceuticals Recent Developments/Updates
6.6 Gyre Pharmaceuticals
6.6.1 Gyre Pharmaceuticals Company Information
6.6.2 Gyre Pharmaceuticals Description and Business Overview
6.6.3 Gyre Pharmaceuticals Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gyre Pharmaceuticals Pirfenidone Drugs Product Portfolio
6.6.5 Gyre Pharmaceuticals Recent Developments/Updates
6.7 Apotex
6.7.1 Apotex Company Information
6.7.2 Apotex Description and Business Overview
6.7.3 Apotex Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Apotex Pirfenidone Drugs Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Teva
6.8.1 Teva Company Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pirfenidone Drugs Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Kawin
6.9.1 Kawin Company Information
6.9.2 Kawin Description and Business Overview
6.9.3 Kawin Pirfenidone Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Kawin Pirfenidone Drugs Product Portfolio
6.9.5 Kawin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Drugs Industry Chain Analysis
7.2 Pirfenidone Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Drugs Production Mode & Process
7.4 Pirfenidone Drugs Sales and Marketing
7.4.1 Pirfenidone Drugs Sales Channels
7.4.2 Pirfenidone Drugs Distributors
7.5 Pirfenidone Drugs Customers
8 Pirfenidone Drugs Market Dynamics
8.1 Pirfenidone Drugs Industry Trends
8.2 Pirfenidone Drugs Market Drivers
8.3 Pirfenidone Drugs Market Challenges
8.4 Pirfenidone Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Accord Healthcare
Amneal Pharmaceuticals
Sandoz Inc
ScieGen Pharmaceuticals
Gyre Pharmaceuticals
Apotex
TEVA
Kawin
List of Tables
 Table 1. Global Pirfenidone Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Pirfenidone Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Pirfenidone Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Pirfenidone Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Pirfenidone Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Pirfenidone Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Pirfenidone Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Pirfenidone Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Pirfenidone Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pirfenidone Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pirfenidone Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Pirfenidone Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pirfenidone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pirfenidone Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pirfenidone Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Pirfenidone Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Pirfenidone Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Pirfenidone Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Pirfenidone Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Pirfenidone Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Pirfenidone Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Pirfenidone Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Pirfenidone Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Pirfenidone Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Pirfenidone Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Pirfenidone Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Pirfenidone Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Pirfenidone Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Pirfenidone Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Pirfenidone Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Pirfenidone Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Pirfenidone Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Pirfenidone Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Pirfenidone Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Pirfenidone Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Pirfenidone Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Pirfenidone Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Pirfenidone Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Pirfenidone Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Pirfenidone Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Pirfenidone Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Pirfenidone Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Pirfenidone Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Pirfenidone Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Pirfenidone Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Pirfenidone Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Pirfenidone Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Pirfenidone Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Pirfenidone Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Pirfenidone Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Pirfenidone Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Pirfenidone Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Pirfenidone Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Pirfenidone Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Pirfenidone Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Pirfenidone Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Pirfenidone Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Pirfenidone Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Pirfenidone Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Pirfenidone Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Pirfenidone Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Pirfenidone Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Pirfenidone Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Pirfenidone Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Pirfenidone Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Pirfenidone Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Pirfenidone Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Pirfenidone Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Roche Pirfenidone Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Accord Healthcare Company Information
 Table 76. Accord Healthcare Description and Business Overview
 Table 77. Accord Healthcare Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Accord Healthcare Pirfenidone Drugs Product
 Table 79. Accord Healthcare Recent Developments/Updates
 Table 80. Amneal Pharmaceuticals Company Information
 Table 81. Amneal Pharmaceuticals Description and Business Overview
 Table 82. Amneal Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Amneal Pharmaceuticals Pirfenidone Drugs Product
 Table 84. Amneal Pharmaceuticals Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Sandoz Pirfenidone Drugs Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. ScieGen Pharmaceuticals Company Information
 Table 91. ScieGen Pharmaceuticals Description and Business Overview
 Table 92. ScieGen Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. ScieGen Pharmaceuticals Pirfenidone Drugs Product
 Table 94. ScieGen Pharmaceuticals Recent Developments/Updates
 Table 95. Gyre Pharmaceuticals Company Information
 Table 96. Gyre Pharmaceuticals Description and Business Overview
 Table 97. Gyre Pharmaceuticals Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Gyre Pharmaceuticals Pirfenidone Drugs Product
 Table 99. Gyre Pharmaceuticals Recent Developments/Updates
 Table 100. Apotex Company Information
 Table 101. Apotex Description and Business Overview
 Table 102. Apotex Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Apotex Pirfenidone Drugs Product
 Table 104. Apotex Recent Developments/Updates
 Table 105. Teva Company Information
 Table 106. Teva Description and Business Overview
 Table 107. Teva Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Teva Pirfenidone Drugs Product
 Table 109. Teva Recent Developments/Updates
 Table 110. Kawin Company Information
 Table 111. Kawin Description and Business Overview
 Table 112. Kawin Pirfenidone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Kawin Pirfenidone Drugs Product
 Table 114. Kawin Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Pirfenidone Drugs Distributors List
 Table 118. Pirfenidone Drugs Customers List
 Table 119. Pirfenidone Drugs Market Trends
 Table 120. Pirfenidone Drugs Market Drivers
 Table 121. Pirfenidone Drugs Market Challenges
 Table 122. Pirfenidone Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pirfenidone Drugs
 Figure 2. Global Pirfenidone Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Pirfenidone Drugs Market Share by Type: 2023 & 2030
 Figure 4. Capsules Product Picture
 Figure 5. Tablets Product Picture
 Figure 6. Global Pirfenidone Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Pirfenidone Drugs Market Share by Application: 2023 & 2030
 Figure 8. Hospital and Clinic
 Figure 9. Retail Pharmacies
 Figure 10. Other
 Figure 11. Global Pirfenidone Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Pirfenidone Drugs Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Pirfenidone Drugs Sales (2019-2030) & (K Units)
 Figure 14. Global Pirfenidone Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 15. Pirfenidone Drugs Report Years Considered
 Figure 16. Pirfenidone Drugs Sales Share by Manufacturers in 2023
 Figure 17. Global Pirfenidone Drugs Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Pirfenidone Drugs Players: Market Share by Revenue in Pirfenidone Drugs in 2023
 Figure 19. Pirfenidone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Pirfenidone Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Pirfenidone Drugs Sales Market Share by Country (2019-2030)
 Figure 22. North America Pirfenidone Drugs Revenue Market Share by Country (2019-2030)
 Figure 23. United States Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Pirfenidone Drugs Sales Market Share by Country (2019-2030)
 Figure 26. Europe Pirfenidone Drugs Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Pirfenidone Drugs Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Pirfenidone Drugs Revenue Market Share by Region (2019-2030)
 Figure 34. China Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Pirfenidone Drugs Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Pirfenidone Drugs Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Pirfenidone Drugs Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Pirfenidone Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Pirfenidone Drugs by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Pirfenidone Drugs by Type (2019-2030)
 Figure 53. Global Pirfenidone Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Pirfenidone Drugs by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Pirfenidone Drugs by Application (2019-2030)
 Figure 56. Global Pirfenidone Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 57. Pirfenidone Drugs Value Chain
 Figure 58. Pirfenidone Drugs Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Pirfenidone Tablets Market Research Report 2024
Global Antifibrotic Drug Market Research Report 2024
Global Idiopathic Pulmonary Fibrosis IPF Drug Market Research Report 2025
Global Pirfenidone Market Research Report 2024
Global Idiopathic Pulmonary Fibrosis Management Market Research Report 2024
Idiopathic Pulmonary Fibrosis Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Idiopathic Pulmonary Fibrosis IPF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Idiopathic Pulmonary Fibrosis Drug Market Research Report 2025
Pulmonary Fibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antifibrotic Drugs Market Insights Forecast to 2030
Global Interstitial Pneumonia Market Research Report 2024
Global Anti Fibrotic Therapy for Ocular Fibrosis Market Insights Forecast to 2030
Global Sulfapyridine Market Research Report 2024
Global Treatment of Skin Fibrosis Market Insights Forecast to 2030
Global Fenspiride Market Research Report 2024
Global Interstitial Lung Disease ILD Market Research Report 2024
Global Etofylline Market Research Report 2025
Global Treprostinil Drugs Market Insights Forecast to 2030
Global Drugs for Respiratory Diseases Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions